$ARDX
ARDELYX, INC.

2024 Q4 Form 10-Q Financial Statement

#000162828024044551 Filed on October 31, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $98.24M
YoY Change 74.21%
Cost Of Revenue $15.73M
YoY Change 104.47%
Gross Profit $82.51M
YoY Change 69.43%
Gross Profit Margin 83.99%
Selling, General & Admin $64.97M
YoY Change 98.9%
% of Gross Profit 78.74%
Research & Development $15.31M
YoY Change 77.26%
% of Gross Profit 18.55%
Depreciation & Amortization $544.0K
YoY Change 87.59%
% of Gross Profit 0.66%
Operating Expenses $80.28M
YoY Change 94.38%
Operating Profit $2.233M
YoY Change -69.82%
Interest Expense -$3.357M
YoY Change -403.25%
% of Operating Profit -150.34%
Other Income/Expense, Net $2.282M
YoY Change 56.3%
Pretax Income -$766.0K
YoY Change -111.22%
Income Tax $43.00K
% Of Pretax Income
Net Earnings -$809.0K
YoY Change -112.2%
Net Earnings / Revenue -0.82%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 236.9M shares 235.4M shares
Diluted Shares Outstanding 235.9M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $190.4M
YoY Change 15.34%
Cash & Equivalents $47.43M
Short-Term Investments $143.0M
Other Short-Term Assets $29.12M
YoY Change 19.85%
Inventory $85.16M
Prepaid Expenses
Receivables $53.20M
Other Receivables $0.00
Total Short-Term Assets $284.1M
YoY Change 17.78%
LONG-TERM ASSETS
Property, Plant & Equipment $1.028M
YoY Change -7.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.332M
YoY Change 244.0%
Total Long-Term Assets $83.77M
YoY Change 73.92%
TOTAL ASSETS
Total Short-Term Assets $284.1M
Total Long-Term Assets $83.77M
Total Assets $367.9M
YoY Change 27.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.82M
YoY Change 104.55%
Accrued Expenses $47.40M
YoY Change 49.54%
Deferred Revenue $7.272M
YoY Change 78.59%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $70.50M
YoY Change 61.96%
LONG-TERM LIABILITIES
Long-Term Debt $100.7M
YoY Change 270.25%
Other Long-Term Liabilities $38.36M
YoY Change 22464.71%
Total Long-Term Liabilities $139.1M
YoY Change 81704.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $70.50M
Total Long-Term Liabilities $139.1M
Total Liabilities $209.6M
YoY Change 113.37%
SHAREHOLDERS EQUITY
Retained Earnings -$890.0M
YoY Change 8.88%
Common Stock $1.048B
YoY Change 3.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $158.3M
YoY Change
Total Liabilities & Shareholders Equity $367.9M
YoY Change 27.12%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$809.0K
YoY Change -112.2%
Depreciation, Depletion And Amortization $544.0K
YoY Change 87.59%
Cash From Operating Activities $501.0K
YoY Change -102.33%
INVESTING ACTIVITIES
Capital Expenditures $137.0K
YoY Change -27.89%
Acquisitions
YoY Change
Other Investing Activities $2.478M
YoY Change -107.62%
Cash From Investing Activities $2.341M
YoY Change -107.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.697M
YoY Change -95.34%
NET CHANGE
Cash From Operating Activities 501.0K
Cash From Investing Activities 2.341M
Cash From Financing Activities 2.697M
Net Change In Cash 5.539M
YoY Change 49.3%
FREE CASH FLOW
Cash From Operating Activities $501.0K
Capital Expenditures $137.0K
Free Cash Flow $364.0K
YoY Change -101.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001437402
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
ARDELYX, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1303944
dei Entity Address Address Line1
EntityAddressAddressLine1
400 Fifth Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Waltham
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02451
dei City Area Code
CityAreaCode
510
dei Local Phone Number
LocalPhoneNumber
745-1700
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001
dei Trading Symbol
TradingSymbol
ARDX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47429000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21470000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
142973000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
162829000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53195000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22031000 usd
CY2024Q3 us-gaap Inventory Gross
InventoryGross
11378000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
12448000 usd
CY2024Q3 ardx Prepaid Commercial Manufacturing Current
PrepaidCommercialManufacturingCurrent
16663000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12460000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8408000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
284098000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
246111000 usd
CY2024Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
73780000 usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
37039000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1218000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
209566000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
130763000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
214976555 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
98329000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
119248000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9600000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-147000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37265000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
191161000 usd
us-gaap Net Income Loss
NetIncomeLoss
-43781000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37265000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1548000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
930000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2973000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2690000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
27518000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
9600000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
31164000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
35530000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
35671000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19152000 usd
ardx Increase Decrease In Prepaid Commercial Manufacturing Expense
IncreaseDecreaseInPrepaidCommercialManufacturingExpense
-6497000 usd
ardx Increase Decrease In Prepaid Commercial Manufacturing Expense
IncreaseDecreaseInPrepaidCommercialManufacturingExpense
3609000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5759000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2671000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3686000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3123000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1056000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
809000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3388000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2880000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
19695000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6466000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4216000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1126000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54619000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-80999000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
120354000 usd
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
36264000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
137644000 usd
dei Entity File Number
EntityFileNumber
001-36485
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
236854270 shares
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2567000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
15041000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
70499000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
50393000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1725000 usd
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
12770000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
8644000 usd
CY2024Q3 ardx Deferred Royalty Obligation Noncurrent
DeferredRoyaltyObligationNoncurrent
24372000 usd
CY2023Q4 ardx Deferred Royalty Obligation Noncurrent
DeferredRoyaltyObligationNoncurrent
20179000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
222782229 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214976555 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
235911399 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
234516305 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
6629000 usd
CY2024Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
286000 usd
CY2023Q4 ardx Prepaid Commercial Manufacturing Current
PrepaidCommercialManufacturingCurrent
18925000 usd
CY2024Q3 ardx Prepaid Commercial Manufacturing Non Current
PrepaidCommercialManufacturingNonCurrent
0 usd
CY2023Q4 ardx Prepaid Commercial Manufacturing Non Current
PrepaidCommercialManufacturingNonCurrent
4235000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3625000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5589000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1028000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1009000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5332000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3596000 usd
CY2023Q4 us-gaap Assets
Assets
297579000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
15824000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11138000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12597000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4435000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7272000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7182000 usd
CY2024Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
100707000 usd
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
49822000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
217486000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90093000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11541000 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
33295000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
236890431 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
236890431 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
232453190 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
232453190 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
24000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
23000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1048073000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1012773000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-846204000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
224000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
158297000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
166816000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
367863000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
297579000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
98241000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56391000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15728000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7692000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32292000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12718000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15310000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8637000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38651000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26012000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64970000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32664000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
182618000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
86653000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
80280000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
41301000 usd
us-gaap Costs And Expenses
CostsAndExpenses
221269000 usd
us-gaap Costs And Expenses
CostsAndExpenses
112665000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2233000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
7398000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-36075000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-35290000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3357000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1107000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
9039000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3210000 usd
CY2024Q3 ardx Non Cash Interest Expense Related To Sale Of Royalties
NonCashInterestExpenseRelatedToSaleOfRoyalties
1924000 usd
ardx Non Cash Interest Expense Related To Sale Of Royalties
NonCashInterestExpenseRelatedToSaleOfRoyalties
5202000 usd
ardx Non Cash Interest Expense Related To Sale Of Royalties
NonCashInterestExpenseRelatedToSaleOfRoyalties
2859000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2282000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1460000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6766000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4308000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-766000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6829000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43550000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37051000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
43000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
231000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
214000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-809000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
6629000 usd
us-gaap Net Income Loss
NetIncomeLoss
-43781000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37265000 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
235911399 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
234516305 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-809000 usd
us-gaap Net Income Loss
NetIncomeLoss
-43781000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37265000 usd
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
9000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-39000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-147000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-523000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6638000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-43820000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37412000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
146990000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96140000 usd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 210
CY2024Q3 us-gaap Assets
Assets
367863000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-889985000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
185000 usd
CY2023Q3 ardx Non Cash Interest Expense Related To Sale Of Royalties
NonCashInterestExpenseRelatedToSaleOfRoyalties
922000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
227894335 shares
CY2024Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1189000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1508000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9133000 usd
CY2024Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
286000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-809000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
158297000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
166816000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2227000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
257000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5299000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27518000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-39000 usd
us-gaap Net Income Loss
NetIncomeLoss
-43781000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
158297000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
123161000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
670000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
40000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
57163000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3489000 usd
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
9000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
6629000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
191161000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
808000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
337000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
251000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
5420000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3093000 usd
ardx Non Cash Royalty Related To Sale Of Future Royalties
NonCashRoyaltyRelatedToSaleOfFutureRoyalties
-1776000 usd
ardx Non Cash Royalty Related To Sale Of Future Royalties
NonCashRoyaltyRelatedToSaleOfFutureRoyalties
0 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-3577000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-1483000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
96634000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
418000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
301000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
23302000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-101681000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
49750000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
119248000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7526000 usd
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1059000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
57276000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
120307000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25959000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-62373000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21470000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47429000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33767000 usd
us-gaap Interest Paid Net
InterestPaidNet
6962000 usd
us-gaap Interest Paid Net
InterestPaidNet
2692000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
272000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
19000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1010000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
339000 usd
us-gaap Stock Issued1
StockIssued1
257000 usd
us-gaap Stock Issued1
StockIssued1
337000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported in the financial statements and accompanying notes thereto. On an ongoing basis, management evaluates its estimates, including those related to recognition of revenue, clinical trial accruals, contract manufacturing accruals, expected demand for inventory, fair value of assets and liabilities, income taxes and stock-based compensation. Management bases its estimates on historical experience and on various other market-specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could materially differ from those estimates.</span></div>
CY2024Q3 us-gaap Investments And Cash
InvestmentsAndCash
190400000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-890000000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47429000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47429000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
142788000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
193000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
142973000 usd
CY2024Q3 ardx Investments And Cash Amortized Cost
InvestmentsAndCashAmortizedCost
190217000 usd
CY2024Q3 ardx Cash Cash Equivalents And Investments Gross Unrealized Gains
CashCashEquivalentsAndInvestmentsGrossUnrealizedGains
193000 usd
CY2024Q3 ardx Cash Cash Equivalents And Investments Gross Unrealized Losses
CashCashEquivalentsAndInvestmentsGrossUnrealizedLosses
8000 usd
CY2024Q3 us-gaap Investments And Cash
InvestmentsAndCash
190402000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21470000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21470000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
162605000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
280000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
56000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
162829000 usd
CY2023Q4 ardx Investments And Cash Amortized Cost
InvestmentsAndCashAmortizedCost
184075000 usd
CY2023Q4 ardx Cash Cash Equivalents And Investments Gross Unrealized Gains
CashCashEquivalentsAndInvestmentsGrossUnrealizedGains
280000 usd
CY2023Q4 ardx Cash Cash Equivalents And Investments Gross Unrealized Losses
CashCashEquivalentsAndInvestmentsGrossUnrealizedLosses
56000 usd
CY2023Q4 us-gaap Investments And Cash
InvestmentsAndCash
184299000 usd
ardx Available For Sale Securities Debt Securities Current Contractual Maturities Maximum
AvailableForSaleSecuritiesDebtSecuritiesCurrentContractualMaturitiesMaximum
P1Y
CY2023 ardx Available For Sale Securities Debt Securities Current Contractual Maturities Maximum
AvailableForSaleSecuritiesDebtSecuritiesCurrentContractualMaturitiesMaximum
P1Y
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0 investment
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0 investment
CY2024Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
25992000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
22920000 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
57335000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
24582000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1831000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1985000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
85158000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
49487000 usd
CY2024Q3 us-gaap Inventory Gross
InventoryGross
11378000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
12448000 usd
CY2024Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
73780000 usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
37039000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
85158000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
49487000 usd
CY2024Q3 ardx Prepaid Commercial Manufacturing
PrepaidCommercialManufacturing
16700000 usd
CY2023Q4 ardx Prepaid Commercial Manufacturing
PrepaidCommercialManufacturing
23200000 usd
CY2024Q3 ardx Prepaid Commercial Manufacturing Non Current
PrepaidCommercialManufacturingNonCurrent
0 usd
CY2023Q4 ardx Prepaid Commercial Manufacturing Non Current
PrepaidCommercialManufacturingNonCurrent
4200000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
98241000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
56391000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
217486000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
90093000 usd
CY2023Q4 ardx Contract With Customer Gross To Net Sales Accruals
ContractWithCustomerGrossToNetSalesAccruals
8628000 usd
ardx Contract With Customer Gross To Net Sales Provisions
ContractWithCustomerGrossToNetSalesProvisions
73862000 usd
ardx Contract With Customer Gross To Credits Or Deductions Issued
ContractWithCustomerGrossToCreditsOrDeductionsIssued
-59170000 usd
CY2024Q3 ardx Contract With Customer Gross To Net Sales Accruals
ContractWithCustomerGrossToNetSalesAccruals
23320000 usd
CY2024Q3 ardx Non Cash Interest Expense Related To Sale Of Royalties
NonCashInterestExpenseRelatedToSaleOfRoyalties
1900000 usd
ardx Non Cash Interest Expense Related To Sale Of Royalties
NonCashInterestExpenseRelatedToSaleOfRoyalties
5200000 usd
CY2023Q3 ardx Non Cash Interest Expense Related To Sale Of Royalties
NonCashInterestExpenseRelatedToSaleOfRoyalties
900000 usd
ardx Non Cash Interest Expense Related To Sale Of Royalties
NonCashInterestExpenseRelatedToSaleOfRoyalties
2900000 usd
ardx Proceeds From Royalty Payments
ProceedsFromRoyaltyPayments
1000000.0 usd
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
104950000 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
944000 usd
CY2024Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
3299000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
100707000 usd
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
0 usd
CY2024Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
100707000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3625000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5589000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2567000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4435000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1218000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1725000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3785000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
6160000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M6D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.066
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.068
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1067000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1061000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
3204000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
3127000 usd
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1229000 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1119000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
3594000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
3316000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1255000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1660000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
702000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
238000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
124000 usd
CY2024Q3 ardx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
21000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4000000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
215000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3785000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2567000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1218000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9133000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3489000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27518000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9600000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
22168000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
8738000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.20
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2228000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.38
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
510000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.46
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
28168000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.57
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
14030000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.49
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-809000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
6629000 usd
us-gaap Net Income Loss
NetIncomeLoss
-43781000 usd
us-gaap Net Income Loss
NetIncomeLoss
-37265000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
235911000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
222782000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
234516000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
214977000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
235911000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
227894000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
234516000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
214977000 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36777000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15183000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35568000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23790000 shares
CY2024Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 usd
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001628280-24-044551-index-headers.html Edgar Link pending
0001628280-24-044551-index.html Edgar Link pending
0001628280-24-044551.txt Edgar Link pending
0001628280-24-044551-xbrl.zip Edgar Link pending
ardx-20240930.htm Edgar Link pending
ardx-20240930.xsd Edgar Link pending
ardx-20240930xex311.htm Edgar Link pending
ardx-20240930xex312.htm Edgar Link pending
ardx-20240930xex321.htm Edgar Link pending
ardx-20240930_g1.jpg Edgar Link pending
exhibit102-xhovionecommerc.htm Edgar Link pending
exhibit105-xardelyxxfourth.htm Edgar Link pending
ardx-20240930_cal.xml Edgar Link unprocessable
ardx-20240930_def.xml Edgar Link unprocessable
ardx-20240930_lab.xml Edgar Link unprocessable
ardx-20240930_pre.xml Edgar Link unprocessable
ardx-20240930_htm.xml Edgar Link completed
exhibit106-xericfosteroffe.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable